http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019505221-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-415 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6881 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0657 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-077 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6869 |
| filingDate | 2017-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2019505221-A |
| titleOfInvention | Genetic markers for engraftment of human ventricular progenitor cells |
| abstract | The present invention provides genetic markers for identifying engraftable human cardiac ventricular progenitor cells. The engraftment marker of the present invention includes an angiogenesis marker and an extracellular matrix marker. Human ventricular progenitor cells that express these markers are capable of forming ventricular tissue in vivo that are vascularized and supported by the extracellular matrix. Also provided is a method of engrafting human cardiac ventricular progenitor cells by transplanting progenitor cells expressing an engraftment marker into a subject. |
| priorityDate | 2016-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 890.